Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Biomarin Pharmaceutical Inc Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $92.2 Billion
- Q3 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 126,674 shares of BMRN stock, worth $8.51 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
126,674
Previous 126,910
0.19%
Holding current value
$8.51 Million
Previous $10.4 Million
14.79%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding BMRN
# of Institutions
638Shares Held
178MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.53 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.3 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.27 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$934 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$705 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...